Focus of Research definition

Focus of Research means the scientific re-education of the immune system to counteract disease entities (“vaccines”) and the “Licensed Rights” shall mean all intellectual property rights licensed by AVT from New York Medical College (“NYMC”) pursuant to the Patent, Know-How and Technology License dated June 24, 2008, as the same may be amended from time to time.

Examples of Focus of Research in a sentence

  • The funding measure is also part of the BMBF’s "Global Health in the Focus of Research" funding scheme (https://www.gesundheitsforschung-bmbf.de/files/Globale_Gesundheit.pdf) and based on the Federal Government’s Global Health Strategy.

  • Focus of Research [Scholarship] Narrative.Dossier Item Instructions 6.

  • Innovative Focus of Research: Policy Networks during Crises and Change The new contribution to knowledge becomes more evident through the use of existing methodology (discussed in Chapter III) to previously unexplored areas of social policy making and implementation.

  • Focus of Research and Overview On October 24, I was asked by the legislative respondents in this case to respond to the petitioners’ expert reports on Pennsylvania’s present congressional redistricting plan, passed into law by the Pennsylvania legislature on December 22, 2011, and under which the 2012, 2014 and 2016 congressional elections were carried out.

  • In-flight Performance Assessment.Future Focus of Research on Performance Assessment.

  • Cappelletti Mauro –Garth , Bryant: Access to Justice as a Focus of Research.

  • Table 2f: Focus of Research, 2012-2016Source: CRDCN Researchers Survey.

  • B.2. Focus of Research Since mid 1990’s region’s countries have started their agricultural reforms, former large scale collective farms has been transformed into different forms of individual farming.

  • Strengthening Rural Families Focus of Research, scholarly and creative works Strengthening rural youth and adults requires a focus on increasing leadership, empowerment and resiliency skills among the family.

  • III Focus of Research and Principles of Selection for Foreign Relations, 1969–1976, Volume XXXVIII, Part 1The purpose of this volume is to document the intellectual founda- tions of the foreign policy of the second Nixon and Ford administra- tions.

Related to Focus of Research

  • scientific research means any activity in the field of natural or applied science for the extension of knowledge;

  • Basic research means any original investigation for the advancement of scientific or technological knowledge that will enhance the research capacity of this state in a way that increases the ability to attract to or develop companies, jobs, researchers, or students in this state.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • Collaboration has the meaning set forth in Section 2.1.

  • Evaluation Team means the team appointed by the City; “Information Meeting” has the meaning set out in section 2.2;

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Benchmarks mean the performance milestones that are set forth in Appendix D.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase IV Clinical Trial means a post-registrational Clinical Trial conducted in any country or countries and required as a condition to, or for the maintenance of, any Regulatory Approval for a Product in the Territory.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Evaluation Criteria means the criteria set out under the clause 27 (Evaluation Process) of this Part C, which includes the Qualifying Criteria, Functional Criteria and Price and Preferential Points Assessment.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.